Background Cell‐free fetal DNA (cff DNA) non‐invasive prenatal testing (NIPT) is rapidly
expanding, and is being introduced at varying rates depending on country and condition …

Context Noninvasive prenatal determination of fetal sex using cell-free fetal DNA provides
an alternative to invasive techniques for some heritable disorders. In some countries this …

Objective—The atheroprotective effects of estrogen are independent of circulating lipid
levels. Whether estrogen regulates transcytosis of LDL (low-density lipoprotein) across the …

Background Cell-free fetal DNA (cffDNA) can be detected in maternal blood during
pregnancy, opening the possibility of early non-invasive prenatal diagnosis for a variety of …

Nowadays, new advances in the use of cell free fetal DNA (cffDNA) in maternal plasma of
pregnant women has provided the possibility of applying cffDNA in prenatal diagnosis as a …

Objective: Diagnosis of fetal gender early in pregnancy is very useful as it would prevent
invasive fetal sampling in almost half the cases at risk of inheriting X-linked disorders or …

Maternal Zika virus (ZIKV) infection during pregnancy can associate with severe intrauterine
growth restriction (IUGR), placental damage, and metabolism disturbance, as well as …

Background Haemophilia A (HA) is the most severe sex-linked bleeding disorder that is
characterized with non-controlled and often threatening Haemorrhage. Routine fetal sex …

Cell-free fetal DNA (cffDNA) is available in the maternal circulation throughout pregnancy
and can be used for noninvasive prenatal diagnosis including, determination of fetal sex …

Prenatal screening and diagnosis are routinely offered at antenatal care clinic visits, and are
important in decision making about the continuation of pregnancies affected by genetic …